| 6579886 |
Selective iglur5 receptor antagonists |
Michael Gregory Bell, Michael Edward Le Tourneau, Michael John Martinelli |
2003-06-17 |
$179,653,000 |
| 6265581 |
Selective .beta.3 adrenergic agonists |
Michael Gregory Bell, Thomas Alan Crowell, Christine Ann Droste, Cynthia Darshini Jesudason, Donald P. Matthews +4 more |
2001-07-24 |
$242,428,000 |
| 6133458 |
Benzo[B]indeno[2, 1-D]thiophene compounds, intermediates, compositions, and methods |
Michael Gregory Bell, Brian S. Muehl |
2000-10-17 |
$162,752,000 |
| 6124311 |
Methods for treating resistant tumors |
Srinivasan Chandrasekhar, Anne H. Dantzig, Robert L. Shepard, James J. Starling |
2000-09-26 |
$300,428,000 |
| 6121292 |
Methods for reversing multidrug resistance |
Srinivasan Chandrasekhar, Anne H. Dantzig, Robert L. Shepard, James J. Starling |
2000-09-19 |
$286,918,000 |
| 6093735 |
Selective .beta.-3 adrenergic agonists |
Michael Gregory Bell, Thomas Alan Crowell, Christine Ann Droste, Cynthia Darshini Jesudason, Donald P. Matthews +4 more |
2000-07-25 |
$314,501,000 |
| 6075040 |
Selective .beta..sub.3 adrenergic agonists |
Michael Gregory Bell, Thomas Alan Crowell, Cynthia Darshini Jesudason, Donald P. Matthews, John H. McDonald, III +3 more |
2000-06-13 |
$150,326,000 |
| 6060492 |
Selective .beta.3 adrenergic agonists |
Michael Gregory Bell, Thomas Alan Crowell, Donald P. Matthews, John H. McDonald, III, David Andrew Neel +1 more |
2000-05-09 |
$155,359,000 |
| 5977154 |
Selective .beta.3 adrenergic agonist |
Michael Gregory Bell, Christine Ann Droste, Cynthia Darshini Jesudason, Christopher J. Rito, Anthony John Shuker |
1999-11-02 |
$60,888,000 |
| 5939443 |
Selective .beta.3 adrenergic agonists |
Michael Gregory Bell, Thomas Alan Crowell, Christine Ann Droste, Donald P. Matthews, John H. McDonald, III +2 more |
1999-08-17 |
$154,268,000 |
| 5856341 |
Benzo B! indeno 2,1-D! thiophene compounds, intermediates, processes, compositions and methods |
Michael Gregory Bell, Brian S. Muehl |
1999-01-05 |
$208,307,000 |
| 5840738 |
Selective .beta.-3 adrenergic agonists |
Michael Gregory Bell, Thomas Alan Crowell, Christine Ann Droste, Cynthia Darshini Jesudason, Donald P. Matthews +4 more |
1998-11-24 |
$147,364,000 |
| 5834488 |
Dihydrobenzo B! indeno 2, 1-D! thiophene compounds, intermediates, processes, compositions and methods |
Michael Gregory Bell, Brian S. Muehl |
1998-11-10 |
$229,270,000 |
| 5808080 |
Selective .beta.3 adrenergic agonists |
Michael Gregory Bell, Thomas Alan Crowell, David Andrew Neel |
1998-09-15 |
$121,140,000 |
| 5786356 |
Selective .beta.3 adrenergic agonists |
Michael Gregory Bell, Thomas Alan Crowell, Donald P. Matthews, John H. McDonald, III, David Andrew Neel +1 more |
1998-07-28 |
$113,899,000 |
| 5552545 |
5-deaza-10-oxo-and 5-deaza-10-thio-5,6,7,8-tetrahydrofolic acids |
Homer L. Pearce |
1996-09-03 |
$12,735,000 |
| 5321150 |
5-deaza-10-oxo- and 5-deaza-10-thio-5,6,7,8-tetrahydrofolic acids |
Homer L. Pearce |
1994-06-14 |
$100,754,000 |
| 5159079 |
2-piperidones as intermediates for 5-deaza-10-oxo- and 5-deaza-10-thio-5,6,7,8-tetrahydrofolic acids |
Homer L. Pearce |
1992-10-27 |
$15,246,000 |
| 4560695 |
Isoxazolyl and isothiazolyl aromatase inhibitors |
Kenneth S. Hirsch, Charles D. Jones, Harold M. Taylor |
1985-12-24 |
$9,072,000 |
